Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma.
DeConti RC; Algazi AP; Andrews S; Urbas P; Born O; Stoeckigt D; Floren L; Hwang J; Weber J; Sondak VK; Daud AI; British Journal Of Cancer, 2010, vol. 103, issue 10, p 1548, ISSN 15321827. ISBN 15321827.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef